Skip to main content

Advertisement

Log in

Advanced Gastrointestinal Diffuse Large B-Cell Lymphoma Presenting with Obstructive Jaundice and Very High CA 19-9 Level Mimicking Pancreatic Adenocarcinoma

  • Case Report
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

References

  1. Psyrri A, Papageorgiou S, Economopoulos T. Primary extranodal lymphomas of stomach: clinical presentation, diagnostic pitfalls and management. Ann Oncol. 2008;19:1992–9. doi:10.1093/annonc/mdn525.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  2. Papaxoinis G, Papageorgiou S, Rontogianni D, Kaloutsi V, Fountzilas G, Pavlidis N, et al. Primary gastrointestinal non-Hodgkin’s lymphoma: a clinicopathologic study of 128 cases in Greece. A Hellenic Cooperative Oncology Group study (HeCOG). Leuk Lymphoma. 2006;47:2140–6.

    Article  PubMed  Google Scholar 

  3. Koch P, del Valle F, Berdel WE, Willich NA, Reers B, Hiddemann W, et al. Primary gastrointestinal non-Hodgkin’s lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter Study GIT NHL 01/92. J Clin Oncol. 2001;19:3861–73.

    CAS  PubMed  Google Scholar 

  4. Ghimire P, Wu GY, Zhu L. Primary gastrointestinal lymphoma. World J Gastroenterol. 2011;17:697–707. doi:10.3748/wjg.v17.i6.697.

    Article  PubMed Central  PubMed  Google Scholar 

  5. Raj M, Ghoshal UC, Choudhuri G, Mohindra S. Primary gastric lymphoma presenting as acute pancreatitis: a case report. JOP. 2013;14:463–5. doi:10.6092/1590-8577/1186.

    PubMed  Google Scholar 

  6. Garcia Marin A, Bernardos Garcia L, Vaquero Rodriguez A, Menchen Viso L, Turegano Fuentes F. Spontaneous gastrosplenic fistula secondary to primary gastric lymphoma. Rev Esp Enferm Dig. 2009;101:76–8.

    CAS  PubMed  Google Scholar 

  7. Barut F, Kandemir NO, Karakaya K, Kokten N, Ozdamar SO. Primary intestinal diffuse large B-cell lymphoma forming multiple lymphomatous polyposis. Turk J Gastroenterol. 2011;22:324–8.

    PubMed  Google Scholar 

  8. Bautista-Quach MA, Ake CD, Chen M, Wang J. Gastrointestinal lymphomas: morphology, immunophenotype and molecular features. J Gastrointest Oncol. 2012;3:209–25. doi:10.3978/j.issn.2078-6891.2012.024.

    PubMed Central  PubMed  Google Scholar 

  9. Otter R, Gerrits WB, vd Sandt MM, Hermans J, Willemze R. Primary extranodal and nodal non-Hodgkin’s lymphoma. A survey of a population-based registry. Eur J Cancer Clin Oncol. 1989;25:1203–10.

    Article  CAS  PubMed  Google Scholar 

  10. Herrmann R, Panahon AM, Barcos MP, Walsh D, Stutzman L. Gastrointestinal involvement in non-Hodgkin’s lymphoma. Cancer. 1980;46:215–22.

    Article  CAS  PubMed  Google Scholar 

  11. Vincent A, Herman J, Schulick R, Hruban RH, Goggins M. Pancreatic cancer. Lancet. 2011;378:607–20. doi:10.1016/S0140-6736(10)62307-0.

    Article  PubMed Central  PubMed  Google Scholar 

  12. Koprowski H, Steplewski Z, Mitchell K, Herlyn M, Herlyn D, Fuhrer P. Colorectal carcinoma antigens detected by hybridoma antibodies. Somatic Cell Genet. 1979;5:957–71.

    Article  CAS  PubMed  Google Scholar 

  13. Bertino G, Ardiri AM, Calvagno GS, Malaguarnera G, Interlandi D, Vacante M, et al. Carbohydrate 19.9 antigen serum levels in liver disease. Biomed Res Int. 2013;2013:6. doi:10.1155/2013/531640

  14. Steinberg W. The clinical utility of the CA 19-9 tumor-associated antigen. Am J Gastroenterol. 1990;85:350–5.

    CAS  PubMed  Google Scholar 

  15. Kim HJ, Kim MH, Myung SJ, Lim BC, Park ET, Yoo KS, et al. A new strategy for the application of CA19-9 in the differentiation of pancreaticobiliary cancer: analysis using a receiver operating characteristic curve. Am J Gastroenterol. 1999;94:1941–6.

    Article  CAS  PubMed  Google Scholar 

  16. Ballehaninna UK, Chamberlain RS. The clinical utility of serum CA 19–9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: an evidence based appraisal. J Gastrointest Oncol. 2012;3:105–19. doi:10.3978/j.issn.2078-6891.2011.021.

    PubMed Central  CAS  PubMed  Google Scholar 

  17. Mann DV, Edwards R, Ho S, Lau WY, Glazer G. Elevated tumour marker CA19-9: clinical interpretation and influence of obstructive jaundice. Eur J Surg Oncol. 2000;26:474–9. doi:10.1053/ejso.1999.0925.

    Article  CAS  PubMed  Google Scholar 

  18. Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, Bouabdallah R, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med. 2002;346:235–42. doi:10.1056/NEJMoa011795.rgb.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors wish to thank Dr Gerald Posner and Dr Susan Smith for their suggestions on this manuscript.

Conflict of Interest

The authors declare that they have no competing interests.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Orimisan Samuel Adekolujo.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adekolujo, O.S., Agu, C., Shamar, I. et al. Advanced Gastrointestinal Diffuse Large B-Cell Lymphoma Presenting with Obstructive Jaundice and Very High CA 19-9 Level Mimicking Pancreatic Adenocarcinoma. J Gastrointest Canc 47, 100–103 (2016). https://doi.org/10.1007/s12029-015-9728-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-015-9728-x

Keywords

Navigation